Patent · US Active

Salt of omecamtiv mecarbil and process for preparing salt

US9988354B2 · kind B2 · utility

18Cited by

7References

7Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Sheng Cui · Lexington, US
Henry Morrison · Dublin, US
Karthik Nagapudi · South San Francisco, US
Shawn D. WALKER · Calabasas, US
Charles Bernard · Moorpark, US
Karl Hansen · Atlantic Highlands, US
Neil Fred Langille · Thousand Oaks, US
Alan Martin Allgeier · Wilmington, US
Steven Mennen · Boston, US
Jacqueline C. S. Woo · Sherwood Park, CA

Key dates

Filing date	Mar 14, 2014
Grant date	Jun 5, 2018
Priority date	—
Expiry date	Mar 14, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are omecamtiv mecarbil dihydrochloride salt forms, compositions and pharmaceutical formulations thereof, and methods for their preparation and use. Omecamtiv mecarbil (AMG 423, CK-1827452), having the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.